Shire gets injunction against Roche over hemophilia drug

ZURICH (Reuters) - Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia drug emicizumab, alleging incomplete and misleading statements surrounding the treatment.

Shire gets injunction against Roche over hemophilia drug
Read More


Bagikan Berita Ini